{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:47:01Z","timestamp":1785527221926,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the high-level talent training program of Chengdu University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05237-8","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:15:48Z","timestamp":1780053348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contezolid and polymyxin B nonapeptide combination reveals antibacterial synergy against multidrug-resistant Acinetobacter baumannii strains"],"prefix":"10.1186","volume":"26","author":[{"given":"Danrui","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangting","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"10459","key":"5237_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GAR Collaborators","year":"2024","unstructured":"Collaborators GAR. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"key":"5237_CR2","doi-asserted-by":"publisher","first-page":"15589","DOI":"10.1038\/ncomms15589","volume":"8","author":"M Yoshida","year":"2017","unstructured":"Yoshida M, Reyes SG, Tsuda S, Horinouchi T, Furusawa C, Cronin L. Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro. Nat Commun. 2017;8:15589.","journal-title":"Nat Commun"},{"issue":"2","key":"5237_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","volume":"16","author":"CM Harding","year":"2018","unstructured":"Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16(2):91\u2013102.","journal-title":"Nat Rev Microbiol"},{"key":"5237_CR4","doi-asserted-by":"publisher","first-page":"126722","DOI":"10.1016\/j.micres.2021.126722","volume":"247","author":"HJ Mea","year":"2021","unstructured":"Mea HJ, Yong PVC, Wong EH. An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation. Microbiol Res. 2021;247:126722.","journal-title":"Microbiol Res"},{"key":"5237_CR5","doi-asserted-by":"crossref","unstructured":"Giammanco A, Cal\u00e0 C, Fasciana T, Dowzicky MJ. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial. mSphere. 2017;2(1):e00310\u201316.","DOI":"10.1128\/mSphere.00310-16"},{"key":"5237_CR6","doi-asserted-by":"publisher","first-page":"744494","DOI":"10.3389\/fphar.2021.744494","volume":"12","author":"T Guo","year":"2021","unstructured":"Guo T, Li M, Sun X, Wang Y, Yang L, Jiao H, et al. Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro\/Vivo Efficacy and Mode of Action. Front Pharmacol. 2021;12:744494.","journal-title":"Front Pharmacol"},{"key":"5237_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jconrel.2023.12.046","volume":"366","author":"Z Cui","year":"2024","unstructured":"Cui Z, Li Y, Qin Y, Li J, Shi L, Wan M, et al. Polymyxin B-targeted liposomal photosensitizer cures MDR A. baumannii burn infections and accelerates wound healing via M(1)\/M(2) macrophage polarization. J Control Release. 2024;366:297\u2013311.","journal-title":"J Control Release"},{"issue":"4","key":"5237_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/jac\/dkac445","volume":"78","author":"SY Kim","year":"2023","unstructured":"Kim SY, Seo HW, Park MS, Park CM, Seo J, Rho J, et al. Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2023;78(4):923\u201332.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5237_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/QCO.0000000000000635","volume":"33","author":"JF Jabbour","year":"2020","unstructured":"Jabbour JF, Sharara SL, Kanj SS. Treatment of multidrug-resistant Gram-negative skin and soft tissue infections. Curr Opin Infect Dis. 2020;33(2):146\u201354.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"5237_CR10","doi-asserted-by":"publisher","first-page":"e0368723","DOI":"10.1128\/spectrum.03687-23","volume":"12","author":"SJ Kim","year":"2024","unstructured":"Kim SJ, Jo J, Kim J, Ko KS, Lee W. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters. Microbiol Spectr. 2024;12(4):e0368723.","journal-title":"Microbiol Spectr"},{"key":"5237_CR11","doi-asserted-by":"publisher","first-page":"998671","DOI":"10.3389\/fmicb.2022.998671","volume":"13","author":"F Al-Marzooq","year":"2022","unstructured":"Al-Marzooq F, Ghazawi A, Tariq S, Daoud L, Collyns T. Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant Escherichia coli. Front Microbiol. 2022;13:998671.","journal-title":"Front Microbiol"},{"key":"5237_CR12","doi-asserted-by":"publisher","first-page":"887941","DOI":"10.3389\/fphar.2022.887941","volume":"13","author":"T Huang","year":"2022","unstructured":"Huang T, Lv Z, Lin J, Zhao K, Zhai L, Wang X, et al. A Potent Antibiotic Combination of Linezolid and Polymycin B Nonapeptide Against Klebsiella pneumoniae Infection In Vitro and In Vivo. Front Pharmacol. 2022;13:887941.","journal-title":"Front Pharmacol"},{"issue":"8","key":"5237_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41429-023-00628-9","volume":"76","author":"A Kimishima","year":"2023","unstructured":"Kimishima A, Sakai K, Honsho M, Matsui H, Wasuwanich P, Watanabe Y, et al. A combination strategy of a semisynthetic macrolide, 5-O-mycaminosyltylonolide with polymyxin B nonapeptide for multi-drug resistance P. aeruginosa. J Antibiot (Tokyo). 2023;76(8):499\u2013501.","journal-title":"J Antibiot (Tokyo)"},{"issue":"3","key":"5237_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s15010-024-02287-w","volume":"52","author":"GX Zhang","year":"2024","unstructured":"Zhang GX, Liu TT, Ren AX, Liang WX, Yin H, Cai Y. Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment. Infection. 2024;52(3):787\u2013800.","journal-title":"Infection"},{"issue":"6","key":"5237_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41429-025-00825-8","volume":"78","author":"L Liu","year":"2025","unstructured":"Liu L, Chen J, Deng Y, Gao F, Lin T, Yang Z, et al. Contezolid, a novel oxazolidinone antibiotic, acts as a potential anti-inflammatory agent. J Antibiot (Tokyo). 2025;78(6):384\u20137.","journal-title":"J Antibiot (Tokyo)"},{"issue":"12","key":"5237_CR16","doi-asserted-by":"publisher","first-page":"e0078923","DOI":"10.1128\/aac.00789-23","volume":"67","author":"D Almeida","year":"2023","unstructured":"Almeida D, Li SY, Lee J, Hafkin B, Mdluli K, Fotouhi N, et al. Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis. Antimicrob Agents Chemother. 2023;67(12):e0078923.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5237_CR17","doi-asserted-by":"publisher","first-page":"e0182824","DOI":"10.1128\/aac.01828-24","volume":"69","author":"Y Huang","year":"2025","unstructured":"Huang Y, Chiaraviglio L, Bode-Sojobi I, Kirby JE. Triple antimicrobial combinations with potent synergistic activity against M. abscessus. Antimicrob Agents Chemother. 2025;69(4):e0182824.","journal-title":"Antimicrob Agents Chemother"},{"key":"5237_CR18","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.2147\/IDR.S413452","volume":"16","author":"S Zhao","year":"2023","unstructured":"Zhao S, Zhang W, Zhang L, Zhang J, Li J, Si L, et al. Use of Contezolid for the Treatment of Refractory Infective Endocarditis in a Patient with Chronic Renal Failure: Case Report. Infect Drug Resist. 2023;16:3761\u20135.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"5237_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41564-018-0322-4","volume":"4","author":"K Zhao","year":"2019","unstructured":"Zhao K, Li W, Li J, Ma T, Wang K, Yuan Y, et al. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat Microbiol. 2019;4(3):459\u201369.","journal-title":"Nat Microbiol"},{"key":"5237_CR20","unstructured":"Patel JB. Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement: Performance standards for antimicrobial susceptibility testing. twenty-fourth informational supplement; 2014."},{"key":"5237_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/AEM.01311-20","volume":"86","author":"K Abdelkader","year":"2020","unstructured":"Abdelkader K, Guti\u00e9rrez D, Grimon D, Ruas-Madiedo P, Lood C, Lavigne R, et al. Lysin LysMK34 of Acinetobacter baumannii Bacteriophage PMK34 Has a Turgor Pressure-Dependent Intrinsic Antibacterial Activity and Reverts Colistin Resistance. Appl Environ Microbiol. 2020;86:19.","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"5237_CR22","doi-asserted-by":"publisher","first-page":"e3000805","DOI":"10.1371\/journal.pbio.3000805","volume":"18","author":"C Rezzoagli","year":"2020","unstructured":"Rezzoagli C, Archetti M, Mignot I, Baumgartner M, K\u00fcmmerli R. Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa. PLoS Biol. 2020;18(8):e3000805.","journal-title":"PLoS Biol"},{"issue":"1","key":"5237_CR23","doi-asserted-by":"publisher","first-page":"2479103","DOI":"10.1080\/21505594.2025.2479103","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wen F, Gou S, Ran Q, Chu Y, Ma W, et al. Multifaceted quorum-sensing inhibiting activity of 3-(Benzo[d][1,3]dioxol-4-yl)oxazolidin-2-one mitigates Pseudomonas aeruginosa virulence. Virulence. 2025;16(1):2479103.","journal-title":"Virulence"},{"issue":"5","key":"5237_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00203-017-1338-5","volume":"199","author":"K Zhao","year":"2017","unstructured":"Zhao K, Li W, Huang T, Song X, Zhang X, Yue B. Comparative transcriptome analysis of Trueperella pyogenes reveals a novel antimicrobial strategy. Arch Microbiol. 2017;199(5):649\u201355.","journal-title":"Arch Microbiol"},{"key":"5237_CR25","doi-asserted-by":"publisher","first-page":"879361","DOI":"10.3389\/fmed.2022.879361","volume":"9","author":"X Gong","year":"2022","unstructured":"Gong X, Zhao Q, Wu Y, Zhou H, Ding S, Zhu K. Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition. Front Med (Lausanne). 2022;9:879361.","journal-title":"Front Med (Lausanne)"},{"key":"5237_CR26","doi-asserted-by":"publisher","first-page":"569173","DOI":"10.3389\/fimmu.2020.569173","volume":"11","author":"T Huang","year":"2020","unstructured":"Huang T, Pu Q, Zhou C, Lin P, Gao P, Zhang X, et al. MicroRNA-302\/367 Cluster Impacts Host Antimicrobial Defense via Regulation of Mitophagic Response Against Pseudomonas aeruginosa Infection. Front Immunol. 2020;11:569173.","journal-title":"Front Immunol"},{"issue":"1","key":"5237_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12879-025-11169-x","volume":"25","author":"FM Adeyemi","year":"2025","unstructured":"Adeyemi FM, Akinlade EA, Yusuf-Omoloye NA, Ajigbewu OH, Dare AP, Wahab AA, et al. Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains. BMC Infect Dis. 2025;25(1):786.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"5237_CR28","doi-asserted-by":"publisher","first-page":"e14510","DOI":"10.1111\/1751-7915.14510","volume":"17","author":"H Br\u00fcssow","year":"2024","unstructured":"Br\u00fcssow H. The antibiotic resistance crisis and the development of new antibiotics. Microb Biotechnol. 2024;17(7):e14510.","journal-title":"Microb Biotechnol"},{"key":"5237_CR29","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/IDR.S169894","volume":"11","author":"EC Eze","year":"2018","unstructured":"Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018;11:2277\u201399.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5237_CR30","doi-asserted-by":"publisher","first-page":"2289769","DOI":"10.1080\/21505594.2023.2289769","volume":"15","author":"M Lucidi","year":"2024","unstructured":"Lucidi M, Visaggio D, Migliaccio A, Capecchi G, Visca P, Imperi F, et al. Pathogenicity and virulence of Acinetobacter baumannii: Factors contributing to the fitness in healthcare settings and the infected host. Virulence. 2024;15(1):2289769.","journal-title":"Virulence"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05237-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05237-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05237-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:10:13Z","timestamp":1785521413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05237-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5237"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05237-8","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"679"}}